Breast Cancer (Diagnostics)

BYU Scientist Develops Serological Test for Breast Cancer Detection

Published in Women's Health Weekly, March 24th, 1997

A new test developed by a Brigham Young University (BYU) scientist might be able to detect breast cancer early, determine how advanced it is, and estimate the chances of it recurring after treatment.

The test measures the levels of thymidine kinase (TK) in a patients blood. The enzyme is produced by several types of cancer. For years scientists have been studying the relationship between elevated TK levels and several types of cancer, including leukemia and prostate, lung, brain, and bone cancer.

BYU microbiologist Kim O'Neill said that the test doesn't specifically detect breast cancer, but could be used to detect malignancy.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1997-03-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry